184 related articles for article (PubMed ID: 33687982)
21. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
Tereskerz PM; Moreno J
Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
[TBL] [Abstract][Full Text] [Related]
22. Task force ready on financial conflict of interest in research.
Maloney DM
Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833561
[No Abstract] [Full Text] [Related]
23. Clinical research and industrial sponsoring: avenues towards transparency and credibility.
Hildebrandt M; Ludwig WD
Onkologie; 2003 Dec; 26(6):529-34. PubMed ID: 14709925
[TBL] [Abstract][Full Text] [Related]
24. Conflict of interest in human subjects research.
Groeger JS; Barnes M
Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
[No Abstract] [Full Text] [Related]
25. [Publication ethics: regulation of financial conflicts of interests in medical journals].
Kakuk P
Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
[No Abstract] [Full Text] [Related]
26. Investigators, industry, and the heuristic device: ethics, patent law, and clinical innovation.
Fins JJ; Schachter M
Account Res; 2001; 8(3):219-33. PubMed ID: 12481768
[No Abstract] [Full Text] [Related]
27. Conflict of interest in biomedical research: a view from Europe.
Salvi M
Sci Eng Ethics; 2003 Jan; 9(1):101-8. PubMed ID: 12645233
[TBL] [Abstract][Full Text] [Related]
28. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
Berger E
Ann Emerg Med; 2008 Aug; 52(2):137-9. PubMed ID: 18672488
[No Abstract] [Full Text] [Related]
29. Navigating US conflict-of-interest rules when commercializing research.
Otrompke J
Nat Biotechnol; 2004 Jul; 22(7):921-4. PubMed ID: 15259191
[No Abstract] [Full Text] [Related]
30. Medicine in the Noise Age: what can we believe?
Angell M
Account Res; 2001; 8(3):189-95. PubMed ID: 12481786
[No Abstract] [Full Text] [Related]
31. Expedited industry-sponsored translational research: a seductive but hazardous cocktail?
Marks JH
Am J Bioeth; 2008 Mar; 8(3):56-8; discussion W1-3. PubMed ID: 18570106
[No Abstract] [Full Text] [Related]
32. Sponsorship by Big Oil, Like the Tobacco Industry, Should be Banned by the Research Community.
Kogevinas M; Takaro T
Epidemiology; 2019 Sep; 30(5):615-616. PubMed ID: 31180931
[No Abstract] [Full Text] [Related]
33. [Transparency in clinical research: registration of clinical trials and publication of results].
Pérez-Mañá C; Llonch C; Farré M
Med Clin (Barc); 2012 Dec; 139(13):593-7. PubMed ID: 22982127
[No Abstract] [Full Text] [Related]
34. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
Krimsky S
Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
[No Abstract] [Full Text] [Related]
35. Is it really all about the money? Reconsidering non-financial interests in medical research.
Saver RS
J Law Med Ethics; 2012; 40(3):467-81. PubMed ID: 23061574
[TBL] [Abstract][Full Text] [Related]
36. Guidance on financial disclosure requirements.
Maloney DM
Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833562
[No Abstract] [Full Text] [Related]
37. Managing financial conflicts of interest.
IRB; 2003; 25(1):7. PubMed ID: 12833898
[No Abstract] [Full Text] [Related]
38. Patenting genes and the public interest.
Nelkin D
Am J Bioeth; 2002; 2(3):13-5. PubMed ID: 12230842
[No Abstract] [Full Text] [Related]
39. Governance of clinical research.
Camilleri M; Tremaine WJ
Am J Gastroenterol; 2012 Mar; 107(3):336-8. PubMed ID: 22388015
[TBL] [Abstract][Full Text] [Related]
40. More regulation of industry-supported biomedical research: are we asking the right questions?
Fry-Revere S; Malmstrom DB
J Law Med Ethics; 2009; 37(3):420-30, 395. PubMed ID: 19723253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
